Wednesday, March 08, 2023 11:18:13 AM
Since then, 2 tings happened.
1) Covid19 mutated
2) People got clot shots (Vaccinated)
3) People got the new problem, Long Haul Covid19 that did not exist yet, when the trial was first applied for an approved.
4) The entire need changed. The good news, is the RVVTF drug is perfect for covid19 and long haul covid19
The awesome news is the FDA did not say Piss Off LOL
Sell if you want folks, lock in a loss. I will putting nets out this year and soaking up more shares now.
What makes you think "Why wouldn’t this have already been included with their proposed symptom relief endpoints?" was not in the proposed end points change request???
Or at least not set up in the request, so the FDA would come back and suggest it?
Some times it is smart to let others think it was their idea. LOLOL
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM